Thermo Fisher Scientific Inc. (TMO) operating KPIs
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)
Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%
Thermo Fisher Scientific mức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%)
IR Financial Reconciliation Package
Latest, FY2025
0.7%
Period ended Dec 31, 2025
Change on a year earlier
+2.0 pts
-1.3% in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Mức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.7% | +2.0 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | -1.3% | -3.1 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 1.8% | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Mức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_margin_chg_pt_lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.